Xylitol & Biofilm Disruption: The Staphylococcus aureus Connection

20 Mar

Written By Joey .

If you've been following recent developments in skin microbiome research, you may have come across xylitol for skin — a naturally occurring sugar alcohol that is quietly building a compelling evidence base far beyond its well-known dental health applications. As a practitioner with a strong interest in microbiome-informed skin care, I've been watching xylitol research closely for several years, and the findings are genuinely exciting — particularly around biofilm disruption, Staphylococcus aureus overgrowth in eczema and atopic dermatitis, Cutibacterium acnes in acne, and structural skin barrier support.

What makes xylitol for skin health particularly interesting from a clinical perspective is its safety profile and selectivity. Unlike broad-spectrum antimicrobials, xylitol appears to target potentially pathogenic organisms while leaving — or even supporting — beneficial commensal bacteria.

◆ Quick Answer

What does xylitol do for skin? Xylitol for skin works through three primary mechanisms: it disrupts pathogenic biofilms (particularly Staphylococcus aureus in eczema and atopic dermatitis), selectively inhibits the growth of harmful bacteria including S. aureus and Cutibacterium acnes at 5% concentration, and supports skin barrier function by upregulating filaggrin, loricrin, and involucrin — the structural proteins that maintain a healthy, hydrated skin barrier.^1,2,3 It does this without disrupting beneficial commensal bacteria like Staphylococcus epidermidis.

What Is Xylitol and Why Is It Relevant to Skin Health?

Xylitol is a naturally occurring pentose sugar alcohol found in small quantities in fruits and vegetables including plums, strawberries, cauliflower, and pumpkin.⁴ Commercially produced by hydrogenation of xylose derived from plant fibres, it has been extensively studied in dental products for decades — its ability to reduce Streptococcus mutans colonisation and inhibit oral biofilm formation is well-established.⁴

The relevance of xylitol for skin health is a more recent and rapidly evolving area. The same properties that make xylitol effective in the oral environment — anti-adherence activity against pathogenic microorganisms and selective modulation of microbial populations — translate meaningfully to the skin microbiome. Combined with its exceptional safety record and skin hydration properties, xylitol presents as a genuinely versatile ingredient for microbiome-focused skin care.

Xylitol and Biofilm Disruption: The Staphylococcus aureus Connection

This is the area of xylitol research I find most clinically compelling, particularly in the context of eczema and atopic dermatitis. Staphylococcus aureus is well-documented to colonise the skin of atopic dermatitis patients heavily — and it doesn't simply sit on the surface. It forms a biofilm — a structured, protective matrix of fibrin fibres and glycocalyx — that adheres to skin, occludes sweat ducts, and drives inflammation through toxin and enzyme release.^5,6

Biofilms are a fundamental clinical challenge because they dramatically reduce the effectiveness of antimicrobials. The protective matrix shields bacteria from antibiotics, germicides, and the immune system — a key reason why antibiotic-resistant S. aureus (including MRSA strains) is prevalent in atopic dermatitis populations.⁶

How Xylitol Disrupts S. aureus Biofilm

📄 Katsuyama et al., J Dermatol Sci (2005) — Parts 1 & 2

After screening approximately 500 substances, this two-part study identified xylitol and farnesol as a synergistic combination against S. aureus biofilm. Xylitol inhibited glycocalyx formation (the polysaccharide component of the biofilm matrix) while farnesol dissolved the fibrin fibres. In a randomised, double-blind, placebo-controlled clinical trial of 17 atopic dermatitis patients, a cream containing 5% xylitol and 0.2% farnesol significantly reduced S. aureus load on skin without affecting the beneficial commensal Staphylococcus epidermidis.^5,6

This selectivity is critical. The goal in atopic dermatitis is not to sterilise the skin but to selectively reduce the pathogenic overgrowth without collateral damage to protective organisms. Xylitol achieves this through anti-adherence mechanisms: rather than directly killing bacteria (which drives resistance), it interferes with the adhesion and structural scaffolding that allows S. aureus to establish itself.⁵

Xylitol and Cutibacterium acnes: Implications for Acne

📄 Anglenius & Tiihonen, Korean J Microbiol (2020)

At 5% (w/v) concentration, xylitol significantly inhibited the growth of both S. aureus (p < 0.001) and both tested strains of C. acnes (p < 0.001 and p < 0.005). Importantly, the growth of S. epidermidis was actually promoted at 1% xylitol concentration and not significantly inhibited at 5% — indicating that xylitol selectively targets pathogenic organisms while preserving and even supporting the commensal protective species.²

This selectivity makes xylitol for skin particularly appealing in acne management. C. acnes is a major driver of acne inflammation and lesion formation. The standard of care — topical or oral antibiotics — carries increasing resistance risks and collateral microbiome disruption. S. epidermidis, by contrast, is a protective commensal that supports innate immune skin defences.² The fact that xylitol selectively inhibits C. acnes while potentially supporting S. epidermidis aligns well with a microbiome-preserving approach to acne treatment.

It is important to note that current evidence is primarily from in vitro studies. The mechanisms are biologically plausible and the in vivo atopic dermatitis data provides supporting clinical context, but further clinical trials specifically in acne populations are needed.

Xylitol for Skin Barrier Function: Beyond Simple Hydration

Filaggrin, Loricrin, Involucrin and Occludin Upregulation

📄 Korponyai et al., Acta Dermato-Venereologica (2016/17)

A 5% glycerol / 5% xylitol formulation applied twice daily for 14 days to participants with dry skin significantly increased skin hydration and elevated filaggrin protein quantity — a critical structural protein that maintains skin hydration by binding keratin fibres. It also decreased transepidermal water loss (TEWL), increased the interdigitation index (dermal-epidermal structural integrity), and improved biomechanical skin properties. These were genuine structural improvements in barrier architecture, not just surface hydration effects.¹

This is complemented by mechanistic research (Payer et al., 2018) demonstrating that xylitol upregulates the mRNA expression of filaggrin, loricrin, involucrin, and occludin in human epidermal keratinocytes.³ These structural proteins form the cornified envelope of the epidermis and regulate tight junctions — the "mortar" between skin cells that prevents excessive water loss and environmental insult. The clinical relevance for eczema and atopic dermatitis is significant: impaired filaggrin expression is a recognised driver of barrier dysfunction in these conditions.

Xylitol, Collagen, and Skin Ageing

Research by Mattila et al. (2005, Gerontology) examining long-term dietary xylitol supplementation in aged rats found a significant increase in newly synthesised collagen and a significant decrease in collagen glycosylation — a form of cross-linking associated with skin ageing and reduced elasticity.⁸ While an animal model study using dietary rather than topical xylitol, it adds an interesting dimension to the broader picture of xylitol for skin health — suggesting potential anti-ageing mechanisms that warrant further human research.

Is Xylitol Safe to Use on Skin?

Yes — xylitol has an excellent topical safety profile and is considered very well tolerated on skin, including sensitive and compromised skin types. It is a naturally occurring substance, non-irritating, and has been used in cosmetic formulations for decades. Unlike conventional antimicrobials, it carries no resistance risk because it works through anti-adherence mechanisms rather than direct bactericidal activity. No clinically significant adverse effects have been reported in topical studies at 1–5%.^2,4

Safety note: Xylitol at concentrations used in skin care (typically 1–5%) is non-toxic, non-irritating, and non-sensitising. It is safe to use alongside other topical actives. Oral xylitol in large doses can have a laxative effect in sensitive individuals, but topical application does not carry this concern.

What Concentration of Xylitol Is Effective for Skin?

The research evidence points to 5% (w/v) as the effective concentration for antimicrobial activity against S. aureus and C. acnes, while lower concentrations (1%) appear sufficient for hydration and barrier support effects. The Katsuyama et al. clinical trial used 5% xylitol with 0.2% farnesol. The Anglenius & Tiihonen in vitro study confirmed that 5% concentration produced statistically significant inhibition of both S. aureus and C. acnes growth, while 1% did not show marked antimicrobial effects for skin bacteria.^2,5

Selectivity: What Makes Xylitol Different from Conventional Antimicrobials

Property	Conventional antimicrobials	Xylitol (5%)
Targets S. aureus	Yes	Yes
Targets C. acnes	Yes (antibiotics)	Yes
Preserves S. epidermidis	No — suppresses commensals	Yes — growth promoted at 1%
Resistance risk	Significant and documented	No known resistance mechanism
Biofilm disruption mechanism	Kill-based (selects for resistance)	Anti-adherence (bypasses resistance)
Barrier support	None	Filaggrin upregulation, TEWL reduction

How Xylitol Fits Into a Broader Skin Microbiome Strategy

From a clinical perspective, xylitol is not a standalone treatment for eczema, acne, or atopic dermatitis. It is, however, a genuinely promising addition to a microbiome-informed approach, with particular relevance in the following contexts:

Atopic dermatitis with suspected S. aureus overgrowth: As a biofilm disruptor and anti-adherence agent, xylitol (ideally combined with farnesol) offers a resistance-free alternative to antibiotics for managing S. aureus colonisation.
Acne where conventional antibiotics have been overused: The selective inhibition of C. acnes while preserving S. epidermidis makes xylitol a biologically intelligent option in the broader acne management toolkit.
Dry, compromised, or barrier-impaired skin: The filaggrin-upregulating, TEWL-reducing properties make xylitol useful in formulations targeting dry or sensitive skin.
Post-antibiotic skin recovery: Xylitol's selectivity for beneficial organisms makes it a rational choice during microbiome recovery following antibiotic courses.

Frequently Asked Questions About Xylitol for Skin

Does xylitol for skin actually work for eczema?

The research is promising. A randomised, double-blind, placebo-controlled clinical trial demonstrated that a 5% xylitol cream significantly reduced S. aureus on atopic dermatitis skin without disrupting beneficial commensals.^5,6 Since S. aureus overgrowth is a key driver of eczema inflammation, targeting its biofilm with xylitol represents a biologically sound and resistance-free strategy. Larger clinical trials are still needed, but the existing evidence supports its use as part of a broader eczema management approach.

Can xylitol help with acne?

In vitro research has demonstrated that 5% xylitol significantly inhibits Cutibacterium acnes growth while preserving — or even promoting — the beneficial commensal Staphylococcus epidermidis.² This selectivity makes xylitol a biologically appealing option in acne management, particularly as part of a microbiome-preserving approach. Clinical trial data specifically in acne patients is still limited, but the mechanistic rationale is well-supported.

Is xylitol the same as using sugar on skin?

No — xylitol is a sugar alcohol, not a sugar, and behaves very differently. Conventional sugars feed pathogenic bacteria and yeast (including Malassezia). Xylitol's five-carbon structure means it cannot be metabolised by most bacteria the same way — which is the basis of its antimicrobial and anti-adherence properties.⁴

How does xylitol compare to antibiotics for skin infections?

Xylitol works by disrupting microbial adhesion and biofilm formation rather than directly killing bacteria — meaning it carries no resistance risk. It also does not disrupt beneficial commensal organisms the way broad-spectrum antibiotics do. For mild to moderate S. aureus colonisation in atopic dermatitis, the evidence supports it as a viable resistance-free alternative.^5,6 For active, severe, or systemic bacterial infections, medical-grade antibiotic treatment remains the standard of care.

What skin conditions can benefit from xylitol?

Based on current research, the most evidence-supported applications of xylitol for skin are: atopic dermatitis and eczema (via S. aureus biofilm disruption), acne (via C. acnes inhibition), dry and barrier-compromised skin (via filaggrin upregulation and TEWL reduction), and potentially seborrheic dermatitis — though the biofilm evidence for Malassezia specifically is less mature than for S. aureus and C. acnes.^1,2,5

Conclusion: Xylitol for Skin — A Genuinely Promising Microbiome-Friendly Ingredient

The research on xylitol for skin is still maturing, but what already exists is compelling and mechanistically coherent. It disrupts pathogenic biofilms without creating resistance. It selectively targets S. aureus and C. acnes while supporting beneficial commensals. It upregulates the structural barrier proteins that keep skin hydrated and protected. And it does all of this safely, with no meaningful adverse effects at concentrations used in skin care.

Xylitol fits naturally into a broader skin microbiome strategy — one that prioritises working with the skin's existing ecosystem rather than repeatedly disrupting it with broad-spectrum antimicrobials.

Want to explore a microbiome-informed approach to your skin condition?

Book a functional skin consultation and let's identify which targeted interventions are right for your specific skin picture.

References

Korponyai C, Szél E, Behány Z, et al. Effects of locally applied glycerol and xylitol on the hydration, barrier function and morphological parameters of the skin. Acta Dermato-Venereologica. 2016;97(2):182–187. doi:10.2340/00015555-2493.
Anglenius H, Tiihonen K. Evaluation of xylitol as an agent that controls the growth of skin microbes: Staphylococcus aureus, Staphylococcus epidermidis, and Cutibacterium acnes. Korean J Microbiol. 2020;56(1):54–58. doi:10.7845/kjm.2020.0001.
Payer E, et al. Beyond the physico-chemical barrier: Glycerol and xylitol markedly yet differentially alter gene expression profiles in human epidermal keratinocytes. Exp Dermatol. 2018;27:280–284.
Ur-Rehman S, et al. Xylitol: A review on bioproduction, application, health benefits, and related safety issues. Crit Rev Food Sci Nutr. 2015;55(11):1514–1528.
Katsuyama M, Ichikawa H, Ogawa S, Ikezawa Z. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci. 2005;38(3):197–205.
Katsuyama M, et al. A novel method to control the balance of skin microflora. Part 2. A study of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci. 2005;38(3):207–213.
Akiyama H, et al. Actions of farnesol and xylitol against Staphylococcus aureus. Chemotherapy. 2002;48(3):122–128.
Mattila PT, Pelkonen P, Knuuttila MLE. Effects of long-term dietary xylitol supplementation on collagen content and fluorescence of the skin in aged rats. Gerontology. 2005;51(3):166–169.
Salli K, et al. Xylitol's health benefits beyond dental health: A comprehensive review. Nutrients. 2019;11(8):1813.
Ammons MCB, Ward LS, James GA. Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel. Int Wound J. 2011;8:268–273.
Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16:143–155.

Joey .